CPT code 20527: Enzyme injection for Dupuytren’s contracture

Key takeaways

CPT code 20527 covers injection of a collagenase enzyme into a palmar fascial cord for Dupuytren’s contracture.

The collagenase drug (Xiaflex) is billed separately under HCPCS J0775, at 58 units for a standard 0.58 mg dose.

The day-2 finger manipulation is billed under CPT 26341, and it pays more than the injection itself.

Apply modifier -LT or -RT for laterality, and expect most commercial payers to require prior authorization.

Practice management software like Pabau links diagnosis codes, modifiers, and procedure notes in one claims workflow.

CPT code 20527 is a billable procedure code for injecting a collagenase enzyme into a palmar fascial cord to treat Dupuytren’s contracture. It covers the injection service only.

A complete course of treatment produces three claim lines, not one. The injection is 20527, the collagenase drug is HCPCS J0775, and the day-2 finger manipulation is CPT 26341. This guide covers the descriptor, modifiers, 2026 Medicare rates, documentation, and all three lines.

CPT code 20527: official descriptor and what it means

Official AMA descriptor: Injection, enzyme (e.g., collagenase), palmar fascial cord (i.e., Dupuytren’s contracture).

In plain terms: The physician injects a collagenase enzyme directly into the fibrous cord causing the finger to contract. The enzyme dissolves collagen within the cord, so the finger can be straightened one to three days later. That finger-extension visit falls outside 20527 and is billed separately under CPT 26341.

Clinical overview: Dupuytren’s contracture and enzyme injection

Dupuytren’s contracture (ICD-10 M72.0) is a progressive fibrotic condition of the palmar fascia, most commonly affecting the ring and little fingers. Collagen deposits accumulate into a cord that draws the finger toward the palm, eventually impairing grip and hand function.

Enzyme injection is one of four main treatment approaches used in hand surgery and plastic surgery practices. Each maps to a different CPT code depending on invasiveness:

• Enzyme injection (collagenase): CPT 20527 – non-surgical, office-based, two-visit protocol
• Needle aponeurotomy: CPT 26040 – percutaneous fasciotomy, no collagenase drug
• Open fasciotomy: CPT 26045 – surgical incision of the cord
• Fasciectomy: CPT 26121 – surgical excision of the palmar fascia, palm only

Medical necessity for CPT 20527 rests on a measured contracture, and both joints carry a 20-degree floor. Payer policies set the range at 20 to 100 degrees for a metacarpophalangeal (MCP) joint. For a proximal interphalangeal (PIP) joint, the range is 20 to 80 degrees.

Recording that angle in the clinical note matters for both HIPAA-compliant documentation and payer authorization.

Modifiers and laterality rules

Laterality and repeat-procedure modifiers are the two main modifier categories for this code. Omitting a laterality modifier on a unilateral hand procedure is a common denial trigger.

When both hands are treated in the same session, the bilateral payment rules apply. CMS assigns 20527 a bilateral surgery indicator of 1, so Medicare pays 150% of the single-code amount for the pair.

Most MACs want that reported on one line with modifier -50 and one unit. Some commercial payers ask for separate -LT and -RT lines instead, so confirm the format before you submit.

Modifier -59 applies when a patient also receives a joint injection at the same visit. Ultrasound-guided small joint injections are coded 20604, and intermediate joints are coded 20606. Either one needs -59 to show a distinct anatomical site.

Guidance changes the code as well as the payment. Without ultrasound, an intermediate joint injection is 20605, which carries 1.71 non-facility RVUs against 2.82 for 20606.

Medicare reimbursement and the 2026 fee schedule

Medicare reimburses CPT code 20527 under the Physician Fee Schedule (PFS). Payment is the code’s total RVUs times the annual conversion factor, adjusted by geographic practice cost index (GPCI) for your Medicare Administrative Contractor (MAC) locality.

CY2026 carries two conversion factors. Qualifying APM participants are paid at $33.5675, and everyone else at $33.4009. The figures below use the lower one.

The work RVU is 0.98, so the injection itself is a modest charge. Most of the revenue exposure sits in the J0775 drug cost, which goes unpaid without prior authorization. The published CMS relative value files carry the RVUs behind every figure here.

Billing the collagenase drug separately: J0775 HCPCS code

CPT 20527 covers the injection procedure only. The collagenase drug (Xiaflex, brand name for collagenase clostridium histolyticum) must be billed under HCPCS J0775 as a separate line item. Failing to bill J0775 means the practice absorbs the entire drug cost.

Key billing rules for J0775 alongside CPT code 20527:

• Units: One unit of J0775 is 0.01 mg of collagenase. A standard 0.58 mg Dupuytren’s dose is 58 units on the claim line.
• NDC number: Include the 11-digit National Drug Code on the claim line. Many payers require it for drug reimbursement on J-codes.
• Place of service: Match the place-of-service code to the CPT 20527 claim line, typically office code 11.
• Diagnosis link: Both the procedure line (20527) and the drug line (J0775) must reference the same ICD-10 diagnosis code, M72.0.
• Prior authorization: PA approval usually covers both the procedure and the drug. Confirm the PA number appears on both claim lines.

Unit definitions change from one J-code to the next, so read the descriptor each time. J0561 is counted in 100,000-unit increments, while J0775 is counted in 0.01 mg.

The drug cost for Xiaflex is significant. Most commercial payers require proof of medical necessity before they approve J0775. Do not administer the drug without confirmed authorization.

Billing the full two-visit protocol

Collagenase treatment runs over two visits, so one episode of care produces three claim lines. Practices that bill only 20527 leave two of them on the table.

The manipulation is the better-paid half of the episode. CPT 26341 carries 3.72 non-facility RVUs against 2.82 for the injection, which is roughly $124 against $94. It also has a 10-day global period, so related follow-up inside that window is not separately billable.

The second visit is a separate encounter with its own note and its own charge. Hand therapy and night splinting often follow it, which is why hand surgeons and physical therapy practices co-manage these patients. Neither service is bundled into 20527.

Documentation requirements for billing CPT 20527

Inadequate documentation is the second most common reason for denial after missing prior authorization. The clinical note must contain all of the following to support medical necessity and pass audit review.

• Diagnosis with ICD-10 code: M72.0, palmar fascial fibromatosis, with laterality specified.
• Contracture degree: Measured MCP or PIP joint contracture angle, in degrees.
• Affected hand and cord location: Right or left hand, which digits, and the anatomical cord identified.
• Functional impairment statement: How the contracture limits hand function or activities of daily living.
• Conservative treatment failure: Prior non-surgical attempts, or the rationale for going straight to injection.
• Informed consent: Signed consent naming the specific procedure and the drug. A general medical consent form works if it captures both.
• Drug administration details: Collagenase lot number, dose administered, and a description of the injection site.

Structured procedure notes and digital intake forms reduce the risk of missing a required element at the time of service. Plenty of denials trace back to documentation that existed at the point of care but never reached the billable record. Our guide to medical forms covers how to structure them.

Prior authorization and payer coverage policies

Most commercial payers require prior authorization for CPT 20527 because Xiaflex carries a significant acquisition cost. The requirement covers the procedure and the drug together. Submitting claims without an approved PA number is a primary denial cause.

Common PA criteria across major payers (verify against each payer’s current Local Coverage Determination or coverage policy before submitting):

• Confirmed diagnosis of Dupuytren’s contracture documented by a hand surgeon or specialist
• MCP contracture of 20 to 100 degrees, or PIP contracture of 20 to 80 degrees
• Single cord identified and accessible for injection
• Positive tabletop test, meaning the patient cannot lay the affected finger and palm flat
• No more than three injections per cord, spaced at least four weeks apart
• Clinical photographs or goniometry measurements supporting contracture severity

Payers commonly ask for evidence that conservative measures were tried, so patient compliance notes belong in the authorization file.

Medicare does not typically require separate prior authorization for CPT 20527. Local Coverage Determinations from your MAC may still impose coverage limitations, so check them before billing.

Related CPT codes for Dupuytren’s contracture

Dupuytren’s contracture billing spans several CPT codes, depending on treatment approach. The table below compares the full family, including the manipulation code that closes the two-visit protocol.

CPT 20526 vs 20527: Key differences

These two codes are frequently confused because they sit adjacent in the CPT range and both describe injections into hand structures. The distinction is anatomical and procedural:

• CPT 20526 is an injection into the carpal tunnel (wrist), using a corticosteroid or local anesthetic. It treats carpal tunnel syndrome, not Dupuytren’s.
• CPT 20527 is an injection into a palmar fascial cord (palm), using an enzyme (collagenase). It dissolves the fibrotic cord causing Dupuytren’s contracture.

Billing 20526 for a Dupuytren’s enzyme injection is a coding error. It will be denied and may trigger a medical necessity audit.

The diagnosis codes differ too. Dupuytren’s uses M72.0, while carpal tunnel syndrome uses G56.0 with laterality subcodes G56.01, G56.02, and G56.03. A mismatched diagnosis-to-CPT pairing flags immediately on claims review. See the AAPC code lookup for the full descriptor text of each.

ICD-10 diagnosis codes that support the claim

Every claim for this procedure requires a medically necessary ICD-10 diagnosis code. The primary family is M72, fibroblastic disorders. The specific code you need is M72.0.

M72.0 has no laterality sub-codes in the current ICD-10-CM code set. Document laterality in the procedure note and apply the -LT or -RT modifier on the CPT 20527 claim line. Some payers cross-reference the modifier against the note, so keep the two consistent.

Coding pitfalls and common billing errors

CPT 20527 has a predictable set of billing errors. Recognizing them before claim submission saves time chasing remittance advice.

• Forgetting J0775: The most frequent error. The procedure gets billed and the drug does not, so the practice absorbs the cost of an expensive biologic.
• Missing prior authorization for J0775: PA may be granted for the procedure without explicitly covering the drug. Confirm the PA approval includes the drug code.
• Using CPT 20526 instead of 20527: Anatomically incorrect. 20526 is for carpal tunnel injections; 20527 is for palmar fascial cord injections.
• Coding a steroid injection as CPT 20527: Per AMA coding resources, CPT 20527 is specific to enzyme injections. A corticosteroid injection into a Dupuytren’s cord does not meet the descriptor. Use a different code, typically 20550 or an unlisted code, depending on what the note supports.
• Missing laterality modifier: Submitting CPT 20527 without -LT or -RT on a unilateral procedure triggers denial from most payers.
• Billing both visits under 20527: The day-2 finger extension is a separate service, coded 26341. Bill it on its own claim line and confirm coverage with the payer.

Most of these errors are caught at charge entry rather than after the remittance advice arrives. A monthly reconciliation between 20527 and J0775 units is the fastest way to find the ones that slipped through.

How Pabau ties 20527 documentation to the claim

In most practices these three lines live in two systems. The contracture measurement and the drug lot number sit in the clinical note, and the charges are entered somewhere else. The drug line then gets added from memory, or not at all.

Practice management software like Pabau keeps both halves on one patient record. Consent, intake answers, the goniometry reading, and the treatment note all attach to the same file. When the coder opens the charge, the supporting documentation is already there.

That matters most on the second visit. The manipulation is its own encounter, so it is easy to miss when the two visits sit in different places. Pabau’s claims management software and connected medical records keep the whole episode in one timeline. So you bill three lines instead of one, and you stop finding unbilled J0775 units at month end.

Stop losing revenue on unbilled drug lines

Pabau's claims management software keeps your procedure notes, diagnosis codes, and modifiers on one record. Submit cleaner claims for CPT 20527 and catch the J0775 line before it goes missing.

Book a demo

Conclusion

Treat 20527 as one line in a three-line episode and most of the denial risk disappears. Practices that bill it as a single procedure are the ones writing off drug costs at month end.

The trade-off worth remembering is timing. Authorization has to be in hand before the drug is drawn up, not after the injection. There is no way to unbill a biologic you have already administered.

Pabau’s claims management software links procedure documentation, diagnosis codes, and modifiers in one workflow. That makes the drug line and the second-visit charge hard to lose. Book a demo to see how it handles musculoskeletal injection billing.

Continue your research

Coding another hand procedure? CPT 11740 breaks down the descriptor, modifiers, and documentation for subungual hematoma drainage.

Billing a digit replantation? CPT 20816 sets out the descriptor, reimbursement, and coding pitfalls for that procedure.

Removing an implanted drug delivery device? CPT 20703 sets out the descriptor, modifiers, and documentation for that removal.

Need a musculoskeletal diagnosis code? M66.9 covers spontaneous tendon rupture and how to link it to a procedure claim.

Handling external fixation billing? CPT 20697 covers the descriptor, modifiers, and documentation that support the claim.

Frequently asked questions